StoneX Group
VVOS icon

StoneX Group’s Vivos Therapeutics VVOS Stock Holding History

StoneX Group’s Portfolio VVOS Stock Details VVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.62K Buy
+28,661
New +$8.61K ﹤0.01% 1891

Other funds holding VVOS

Centurion Wealth Management
Centurion Wealth Management Mclean, Virginia $415M AUM 17.23% 1-Year Est. Return
B. Riley Wealth Advisors
B. Riley Wealth Advisors Boca Raton, Florida $2.57B AUM 28.13% 1-Year Est. Return
Acorn Wealth Advisors
Acorn Wealth Advisors Grand Blanc, Michigan $407M AUM 14.44% 1-Year Est. Return
HB Wealth Management
HB Wealth Management Atlanta, Georgia $19.5B AUM 16.96% 1-Year Est. Return
SignatureFD
SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return
Blue Trust Inc
Blue Trust Inc Alpharetta, Georgia $9.5B AUM 13.02% 1-Year Est. Return
LA
Latitude Advisors Vero Beach, Florida $323M AUM 17.08% 1-Year Est. Return
Kozak & Associates
Kozak & Associates Highlands Ranch, Colorado $553M AUM 17.51% 1-Year Est. Return

StoneX Group's VVOS Position: Q3 2026 in Review

StoneX Group opened a new position in Vivos Therapeutics (VVOS) in Q3 2026: 28,661 shares worth $5.62K. The stake represents ﹤0.01% of the portfolio and ranks #1891 among its holdings.

9 funds tracked by Wall St. Rank hold VVOS as of Q3 2026.

  • StoneX Group held 28,661 shares of Vivos Therapeutics worth $5.62K as of Q3 2026.
  • Vivos Therapeutics was a new StoneX Group position in Q3 2026.
  • Vivos Therapeutics made up ﹤0.01% of StoneX Group's portfolio in Q3 2026, its #1891 holding.
  • 9 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q3 2026.

Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.